AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

EBOS GROUP LIMITED

20.020

-0.060-0.30%

Volume:112.58K

Turnover:2.27M

Market Cap:4.10B

PE:17.72

High:20.670

Open:20.410

Low:20.020

Close:20.080

52wk High:37.582

52wk Low:19.880

Shares:205.02M

Float Shares:164.12M

Volume Ratio:1.03

T/O Rate:0.07%

Dividend:0.98

Dividend Rate:4.88%

EPS(TTM):1.130

EPS(LYR):1.090

ROE:8.97%

ROA:3.56%

PB:1.49

PE(LYR):18.37

Loading ...

Overview Company News Filings

Ebos's 1H Result Probably Enough to Rebuild Investor Confidence -- Market Talk

BRIEF-EBOS Group Anticipate A Step-Up In Cash Flows From FY27

EBOS Group Posts Lower Fiscal H1 Underlying Earnings, Higher Revenue; Reaffirms Fiscal 2026 Outlook

MT Newswires Live

EBOS Group H1 Revenue AUD 300 Million

THOMSON REUTERS

EBOS Group H1 Revenue AUD 6,768 Million

THOMSON REUTERS

EBOS Group Ltd - Anticipate a Step-up in Cash Flows From FY27

THOMSON REUTERS

ASX Biggest Losers

MT Newswires Live

EBOS Group Ltd-NZX Capital Change Notice

THOMSON REUTERS

ASX Biggest Losers

MT Newswires Live

EBOS Group Ltd-NZX Performance Rights Update

THOMSON REUTERS

EBOS Group Ltd-NZX Performance Rights Update

THOMSON REUTERS

Large Caps Could Be Ready to Return to New Zealand in 2026 -- Market Talk

NZX Midday Sector Update: Health Technology Advances, Consumer Durables Decline

MT Newswires Live

EBOS Group Ltd-NZX Performance Rights Update

THOMSON REUTERS

Ebos Group Reaffirms Fiscal 2026 Underlying EBITDA Guidance

MT Newswires Live

Ebos Group Opens New Pharmacy Distribution Center in Western Sydney

MT Newswires Live

EBOS Group Ltd-EBOS Announces Opening of New Site in Western Sydney

THOMSON REUTERS

Algorae Pharmaceuticals Expands Commercial Footprint with New Cadila Partnership

Ebos Gets Bull as Earnings Base Nears Reset -- Market Talk

Ebos Shakes Bear Following Post-Results Selloff -- Market Talk

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/EBO.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EBO.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"EBO.AU\",,,,,undefined,":{"symbol":"EBO.AU","market":"AU","secType":"STK","nameCN":"EBOS GROUP LIMITED","latestPrice":20.02,"timestamp":1772169120000,"preClose":20.08,"halted":0,"volume":112580,"delay":0,"changeRate":-0.002988047808764877,"nameEN":"EBOS GROUP LIMITED","floatShares":164124117,"shares":205019637,"eps":1.129828,"marketStatus":"Market Closed","change":-0.06,"latestTime":"02-27 16:12:00 AEDT","open":20.41,"high":20.67,"low":20.02,"amount":2271528,"amplitude":0.032371,"askPrice":20.42,"askSize":980,"bidPrice":20,"bidSize":1300,"shortable":3,"etf":0,"ttmEps":1.129828,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1772406000000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":20.08,"dividendRate":0.048846,"openAndCloseTimeList":[[1772146800000,1772168400000]],"volumeRatio":1.030178803839673,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"EBO.AU\",,,,,undefined,":{"symbol":"EBO.AU","floatShares":164124117,"roa":"3.56%","roe":"8.97%","lyrEps":1.09,"volumeRatio":1.030178803839673,"shares":205019637,"dividePrice":0.9779,"high":20.67,"amplitude":0.032371,"preClose":20.08,"low":20.02,"week52Low":19.88,"pbRate":"1.49","psRate":"0.31","week52High":37.582,"institutionHeld":0,"latestPrice":20.02,"committee":0.140351,"eps":1.129828,"divideRate":0.048846,"volume":112580,"delay":0,"ttmEps":1.129828,"open":20.41,"prevYearClose":23.64,"prevWeekClose":20.6,"prevMonthClose":20.02,"prevQuarterClose":23.64,"fiveDayClose":20.6,"twentyDayClose":22.1,"sixtyDayClose":24.73,"dividendPayoutRate":1.0283624229793926,"dividendGrowthYears":2,"dividendGrowthRate":0.020071382594797148,"fiveYearAvgDividendRate":0.028634014092226722},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EBO.AU\",params:#limit:5,,,undefined,":[{"date":"2026-03-05","symbol":"EBO.AU","amount":0.595147,"announcedDate":"2026-02-25","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-03-06","defaultRemindTime":1772665200000,"name":"EBOS GROUP LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-06","currency":"NZD","dateTimestamp":1772629200000,"payDate":"2026-03-27"},{"date":"2025-09-04","symbol":"EBO.AU","amount":0.4919,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-05","defaultRemindTime":1756944000000,"name":"EBOS GROUP LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-05","currency":"AUD","dateTimestamp":1756908000000,"payDate":"2025-09-24"},{"date":"2025-02-27","symbol":"EBO.AU","amount":0.45443,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-02-28","name":"EBOS GROUP LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-21","payableDate":"2025-02-28","currency":"AUD","dateTimestamp":1740574800000,"payDate":"2025-03-21"},{"date":"2024-08-29","symbol":"EBO.AU","amount":0.56602,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-08-30","defaultRemindTime":1724889600000,"name":"EBOS GROUP LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-09-18","payableDate":"2024-08-30","currency":"AUD","dateTimestamp":1724853600000,"payDate":"2024-09-18"},{"date":"2024-02-29","symbol":"EBO.AU","amount":0.47558,"announcedDate":"2024-02-21","type":"dividend","market":"AU","newRecordDate":"2024-03-01","defaultRemindTime":1709161200000,"name":"EBOS","recordDate":"2024-03-22","payableDate":"2024-03-01","currency":"AUD","dateTimestamp":1709125200000,"payDate":"2024-03-22"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EBO.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-24","recordDate":"2020-09-25","paymentDate":"2020-10-09","value":0.017647,"currency":"NZD"},{"executeDate":"2021-03-04","recordDate":"2021-03-05","paymentDate":"2021-03-18","value":0.01875,"currency":"NZD"},{"executeDate":"2021-09-09","recordDate":"2021-09-10","paymentDate":"2021-09-24","value":0.0202941,"currency":"NZD"},{"executeDate":"2022-03-03","recordDate":"2022-03-04","paymentDate":"2022-03-18","value":0.0207352,"currency":"NZD"},{"executeDate":"2022-09-08","recordDate":"2022-09-09","paymentDate":"2022-09-30","value":0.0216176,"currency":"NZD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EBO.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2614064103","title":"Ebos's 1H Result Probably Enough to Rebuild Investor Confidence -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2614064103","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614064103?lang=en_us&edition=fundamental","pubTime":"2026-02-26 10:26","pubTimestamp":1772072760,"startTime":"0","endTime":"0","summary":"0226 GMT - Forsyth Barr says pharmacy chain owner Ebos's 1H result was in line with its expectations, but by no means perfect. Community Pharmacy revenue beat consensus hopes. Contract Logistics growth was strong, while retaining FY 2026 guidance was another positive, Forsyth Barr says. It says negatives are the low quality of earnings, weak cash flow, and a miss on Community Pharmacy margins. \"Overall, we think the result has done enough to provide the building blocks to rebuild investor confidence and meaningfully reduces the downside risks from here, but it will not be an overnight fix,\" analyst Matt Montgomerie says. Ebos is down 0.3% at NZ$24.02 today. Forsyth Barr retains an outperform call on the stock and trims its price target by 3.9% to NZ$35.80/share. ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK8046","BK7103","EBO.NZ","EBO.AU"],"gpt_icon":0},{"id":"2614720494","title":"BRIEF-EBOS Group Anticipate A Step-Up In Cash Flows From  FY27","url":"https://stock-news.laohu8.com/highlight/detail?id=2614720494","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614720494?lang=en_us&edition=fundamental","pubTime":"2026-02-25 09:35","pubTimestamp":1771983344,"startTime":"0","endTime":"0","summary":"BRIEF-EBOS Group Anticipate A Step-Up In Cash Flows From  FY27Feb 25 (Reuters) - EBOS Group Ltd EBO.AX:ANTICIPATE A STEP-UP IN CASH FLOWS FROM  FY27Further company coverage: EBO.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nFWN3ZK0R9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EBO.AU","BK7103"],"gpt_icon":0},{"id":"2614728796","title":"EBOS Group Posts Lower Fiscal H1 Underlying Earnings, Higher Revenue; Reaffirms Fiscal 2026 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2614728796","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614728796?lang=en_us&edition=fundamental","pubTime":"2026-02-25 05:18","pubTimestamp":1771967935,"startTime":"0","endTime":"0","summary":"EBOS Group  reported Wednesday fiscal first-half underlying earnings of AU$0.614 per share, down from AU$0.675 a year earlier.Analysts polled by FactSet expected earnings of AU$0.61.Revenue for the six months ended Dec. 31, 2025, was AU$6.77 billion, compared with AU$5.99 billion a year earlier. Analysts surveyed by FactSet expected AU$6.48 billion.The company reaffirmed its fiscal 2026 underlying earnings before interest, taxes, depreciation, and amortization guidance of AU$615 million to AU$635 million.The board declared an interim dividend of NZ$0.57 per share, unchanged from the prior corresponding period, payable March 27 to shareholders on record as of March 6.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7103","EBO.AU"],"gpt_icon":0},{"id":"2614747182","title":"EBOS Group H1 Revenue AUD 300 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2614747182","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614747182?lang=en_us&edition=fundamental","pubTime":"2026-02-25 04:33","pubTimestamp":1771965188,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nPLXA08326:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7103","EBO.AU"],"gpt_icon":0},{"id":"2614742495","title":"EBOS Group H1 Revenue AUD 6,768 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2614742495","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614742495?lang=en_us&edition=fundamental","pubTime":"2026-02-25 03:41","pubTimestamp":1771962102,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nPLX62F696:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EBO.AU","BK7103"],"gpt_icon":0},{"id":"2614424997","title":"EBOS Group Ltd - Anticipate a Step-up in Cash Flows From  FY27","url":"https://stock-news.laohu8.com/highlight/detail?id=2614424997","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614424997?lang=en_us&edition=fundamental","pubTime":"2026-02-25 03:41","pubTimestamp":1771962077,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nFWN3ZK0R9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7103","EBO.AU"],"gpt_icon":0},{"id":"2608438628","title":"ASX Biggest Losers","url":"https://stock-news.laohu8.com/highlight/detail?id=2608438628","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608438628?lang=en_us&edition=fundamental","pubTime":"2026-02-03 11:20","pubTimestamp":1770088812,"startTime":"0","endTime":"0","summary":"Here are the 10 ASX-listed companies with the biggest losses on Tuesday.Contact Energy : -5%, AU$8.06Ventia Services Group : -4%, AU$5.55Telix Pharmaceuticals : -3%, AU$10.14Ebos Group : -2%, AU$21.9Mineral Resources : -2%, AU$55.24Meridian Energy : -2%, AU$4.83ARB : -2%, AU$25.81Abacus Storage King : -2%, AU$1.53Virgin Australia Holdings : -2%, AU$3.1Summerset Group Holdings  : -1%, AU$10","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7060","BK7006","CEN.AU","BK7051","BK7113","BK7504","BK7030","SNZ.AU","ASK.AU","VNT.AU","EBO.AU","BK7103","MIN.AU","ARB.AU","BK7055","VGN.AU","BK7151","MEZ.AU","TLX.AU","BK7507","BK7067","BK7095"],"gpt_icon":0},{"id":"2604159862","title":"EBOS Group Ltd-NZX Capital Change Notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2604159862","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604159862?lang=en_us&edition=fundamental","pubTime":"2026-01-20 07:27","pubTimestamp":1768865223,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260119:nTUE71W6SB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7103","EBO.AU"],"gpt_icon":0},{"id":"2603709578","title":"ASX Biggest Losers","url":"https://stock-news.laohu8.com/highlight/detail?id=2603709578","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603709578?lang=en_us&edition=fundamental","pubTime":"2026-01-13 09:37","pubTimestamp":1768268276,"startTime":"0","endTime":"0","summary":"Here are the ASX-listed companies with the biggest losses on Tuesday.GQG Partners : -6%, AU$1.68Zip : -5%, AU$3.355Viva Energy Group : -4%, AU$1.982Endeavour Group : -4%, AU$3.66Mesoblast : -4%, AU$2.745Ampol : -3%, AU$30.19Life360 : -2%, AU$30.88EBOS Group : -2%, AU$22.99Block : -2%, AU$104.54Super Retail Group : -2%, AU$14.65","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7158","ALD.AU","BK7040","SUL.AU","BK7062","BK7065","EDV.AU","BK7016","GQG.AU","BK7508","EBO.AU","BK7067","XYZ.AU","BK7128","BK7103","ZIP.AU","BK7093","360.AU","VEA.AU","MSB.AU","BK7501"],"gpt_icon":0},{"id":"2601707890","title":"EBOS Group Ltd-NZX Performance Rights Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2601707890","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601707890?lang=en_us&edition=fundamental","pubTime":"2026-01-05 08:24","pubTimestamp":1767572667,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nTUE919NBJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7103","EBO.AU"],"gpt_icon":0},{"id":"2588704564","title":"EBOS Group Ltd-NZX Performance Rights Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2588704564","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588704564?lang=en_us&edition=fundamental","pubTime":"2025-12-02 08:22","pubTimestamp":1764634942,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nTUE6LQDC8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EBO.AU","BK7103"],"gpt_icon":0},{"id":"2588719638","title":"Large Caps Could Be Ready to Return to New Zealand in 2026 -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2588719638","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588719638?lang=en_us&edition=fundamental","pubTime":"2025-12-01 08:13","pubTimestamp":1764547980,"startTime":"0","endTime":"0","summary":"0013 GMT - A top theme for New Zealand's equity market in 2026: The return of the large caps. That is the view of Forsyth Barr, which says it is entering 2026 with a strong sense of optimism as New Zealand's economy recovers. In New Zealand this year, mid-cap stocks had their strongest relative performance to large caps since 2006, analyst Matt Montgomerie says. And that script could flip. \"We currently have the lowest estimated total return spread between large caps and mid/small caps for the last decade,\" Forsyth Barr says. Its top five stocks for 2026 are SkyCity Entertainment, Oceania Healthcare, Mainfreight, Ebos, and Port of Tauranga. ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK8037","BK8046","EBO.AU","BK8036","BK7103","BK8050","OCA.NZ","SKC.AU","EBO.NZ","NZ20C.NZ","POT.NZ","BK7078","BK4131","SKC.NZ","T10G.NZ","MFGHF","NZ50G.NZ"],"gpt_icon":0},{"id":"2579154573","title":"NZX Midday Sector Update: Health Technology Advances, Consumer Durables Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=2579154573","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579154573?lang=en_us&edition=fundamental","pubTime":"2025-10-30 09:02","pubTimestamp":1761786137,"startTime":"0","endTime":"0","summary":"Health technology shares gained the most on New Zealand's Exchange, rising past 1% by midday Thursday.Shares of Ebos Group  rose nearly 2% in recent trade.The company on Wednesday reaffirmed its fiscal year 2026 underlying earnings before interest, taxes, depreciation, and amortization guidance of AU$615 million to AU$635 million, skewed to the second half of the year.Meanwhile, the consumer durables sector fell past 3%.KMD Brands  was down past 3% in recent trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KMD.AU","NZ20C.NZ","NZX.NZ","BK7128","BK7103","T10G.NZ","BK8020","EBO.AU","NZ50G.NZ"],"gpt_icon":0},{"id":"2579374156","title":"EBOS Group Ltd-NZX Performance Rights Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2579374156","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579374156?lang=en_us&edition=fundamental","pubTime":"2025-10-30 08:01","pubTimestamp":1761782505,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nTUE5WLC2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EBO.AU","BK7103"],"gpt_icon":0},{"id":"2579372918","title":"Ebos Group Reaffirms Fiscal 2026 Underlying EBITDA Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2579372918","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579372918?lang=en_us&edition=fundamental","pubTime":"2025-10-29 05:26","pubTimestamp":1761686816,"startTime":"0","endTime":"0","summary":"Ebos Group (ASX:EBO, NZE:EBO) reaffirmed its fiscal 2026 underlying earnings before interest, taxes, depreciation, and amortization guidance of AU$615 million to AU$635 million, skewed to the second half of the year, according to a Wednesday filing with the Australian and New Zealand bourses.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XAO.AU","EBO.NZ","XKO.AU","BK8046","XJO.AU","EBO.AU","BK7103"],"gpt_icon":0},{"id":"2578323671","title":"Ebos Group Opens New Pharmacy Distribution Center in Western Sydney","url":"https://stock-news.laohu8.com/highlight/detail?id=2578323671","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578323671?lang=en_us&edition=fundamental","pubTime":"2025-10-28 05:36","pubTimestamp":1761600974,"startTime":"0","endTime":"0","summary":"Ebos Group  opened its new Symbion pharmacy wholesale distribution center in Kemps Creek, Sydney, the sixth site in its AU$360 million distribution center renewal program, according to a Tuesday filing with the New Zealand and Australian bourses.The Kemps Creek center serves 1,500 New South Wales customers, with capacity to expand, and features on-site energy generation via a 1.8-megawatt solar array, three 706-kilowatt  bio-diesel generators, and a 669 kW battery, the filing said.The old Sydney center is set to close by fiscal 2026.The company expects a 30% reduction in annual capital expenditure following the completion of the renewal program in 2026, with only two sites remaining, the filing added.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EBO.NZ","BK8046","WRN","BK7103","EBO.AU","BK4168"],"gpt_icon":0},{"id":"2578459675","title":"EBOS Group Ltd-EBOS Announces Opening of New Site in Western Sydney","url":"https://stock-news.laohu8.com/highlight/detail?id=2578459675","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578459675?lang=en_us&edition=fundamental","pubTime":"2025-10-28 04:35","pubTimestamp":1761597347,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251027:nTUE4S3JXX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EBO.AU","BK7103"],"gpt_icon":0},{"id":"2576600257","title":"Algorae Pharmaceuticals Expands Commercial Footprint with New Cadila Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2576600257","media":"Small Caps","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576600257?lang=en_us&edition=fundamental","pubTime":"2025-10-20 07:56","pubTimestamp":1760918195,"startTime":"0","endTime":"0","summary":"Algorae Pharmaceuticals and private Indian company Cadila Pharmaceuticals have entered into a licence and supply agreement covering two new generic medicines for the Australian and New Zealand markets.The agreement will formalise an operational framework for the partnership and will see Algorae commence planning for Therapeutic Goods Administration  registration to enable commercialisation of the products, which will target key therapeutic areas including cardiovascular and metabolic disorders.Cadila operates manufacturing facilities in the US, UK, European Union, and Australia, and its products are distributed in over 100 countries, supported by a workforce of more than 9,000 professionals and a research and development division comprising more than 350 scientists.Algorae chief commercial officer Vishal Shah said the agreement would expand Algorae’s commercial footprint into new regions.“This deal represents an important step in executing our commercial strategy and expanding our prod","market":"nz","thumbnail":"https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/10/Algorae-Pharmaceuticals-ASX-1AI-Expands-Commercial-Footprint-Cadila-Partnership.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/10/Algorae-Pharmaceuticals-ASX-1AI-Expands-Commercial-Footprint-Cadila-Partnership.jpg"],"rights":{"source":"smallcap_stock","url":"https://smallcaps.com.au/algorae-pharmaceuticals-expands-commercial-footprint-new-cadila-partnership/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://smallcaps.com.au/algorae-pharmaceuticals-expands-commercial-footprint-new-cadila-partnership/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"smallcap_stock","symbols":["1AI.AU","BK7001","XKO.AU","XJO.AU","BK7067","XAO.AU","BK7103","EBO.AU","TGA","TGA.AU","BK4213"],"gpt_icon":0},{"id":"2570707053","title":"Ebos Gets Bull as Earnings Base Nears Reset -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2570707053","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570707053?lang=en_us&edition=fundamental","pubTime":"2025-09-25 10:02","pubTimestamp":1758765720,"startTime":"0","endTime":"0","summary":"0202 GMT - Pharmacy group Ebos gets a new bull in Forsyth Barr, which sees FY 2026 as a year when its earnings base is reset. Analyst Matt Montgomerie says it is heartening that Ebos's FY 2026 guidance implies a sequential stabilization in Ebitda margins from a weak 2H of FY 2025. \"Beyond FY 2026, we believe the combination of improved facility utilization, boosted pharmacy wholesaler funding, gradual retendering of pharmacy contracts, and financial leverage should provide robust EPS growth,\" Forsyth Barr says. It forecasts EPS rising at a compound annual rate of 10% in FY 2025-FY 2029. Forsyth Barr upgrades Ebos to outperform from neutral. Ebos is down 1% at NZ$28.89. ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7103","EBO.NZ","BK8046","EBO.AU"],"gpt_icon":0},{"id":"2568287109","title":"Ebos Shakes Bear Following Post-Results Selloff -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2568287109","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568287109?lang=en_us&edition=fundamental","pubTime":"2025-09-19 09:00","pubTimestamp":1758243600,"startTime":"0","endTime":"0","summary":"0100 GMT - Pharmaceutical supplier Ebos shakes its bear at Citi following the recent sharp selloff in its stock. With the stock down by more than 25% since the dual-listed company reported its annual results on Aug. 27, the investment bank raises its recommendation to neutral from sell. Analyst Laura Sutcliffe says shares are now trading at about 17 times estimated FY 2027 core earnings, which is close to their historical average. She sets her target price a little lower to reflect the softer-than-expected margins reported last month. Citi cuts its target price on Ebos's Australia-listed stock by 12.5% to A$28.00. Shares are up 3.0% at A$26.15. ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["POST","BK4212","EBO.AU","EBO.NZ","BK7103","BK8046"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":22,"code":"91000000","status":"200"}]}}